89bio Ltd.   Report issue

For profit Phase 2
Founded: San Francisco CA United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04048135
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

89bio, Inc. | 89bio Ltd.